Curaleaf(OTC) CURLF

Market Cap$2.07B

Since IPO (2018)-60%

5 Year-75%

1 Year-16%

1 Month-22%

$7.83

-6.79%

-0.57Today

Curaleaf last closing stock price
Metric	Price	Date
Last close	USD 7.83	2026-10-16

Curaleaf stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-16.61%	USD 9.39	2026-10-09
1 month	-21.54%	USD 9.98	2026-09-16
3 month	-16.26%	USD 9.35	2026-07-17
Year to date	+3.57%	USD 7.56	2025-12-31
1 year	-16.35%	USD 9.36	2025-10-16
3 year	-36.03%	USD 12.24	2023-10-17
5 year	-75.31%	USD 31.71	2021-10-15
Since inception	-60.21%	USD 19.68	2018-10-30

Curaleaf Financials at a Glance

Market Cap

$2.07B

Revenue (TTM)

$1.32B

Net Income (TTM)

-$36.43M

EPS (TTM)

-$0.18

P/E Ratio

-43.77

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$7.83

Volume

246,955

Open

$8.28

Price

$7.83

Volume

246,955

Open

$8.28

Previous Close

$7.83

Daily Range

$7.82 - $8.44

52-Week Range

$5.40 - $15.15

Estimated Earnings Date

Nov 3, 2026

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$7.83

Volume

246,955

Open

$8.28

Previous Close

$7.83

Daily Range

$7.82 - $8.44

52-Week Range

$5.40 - $15.15

Estimated Earnings Date

Nov 3, 2026

CURLF News

Investor at home looking at multiple charts Getty Images.jpg

The Deep Value Play for Growth Investors Isn't Artificial Intelligence, It's This Forgotten Industry

David Jagielski, CPAOct 13, 2026

Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?

Eric VolkmanAug 20, 2026

5 Best Cannabis ETFs for 2026 and How to Invest

Keith SpeightsAug 12, 2026

Is Acquiring Aurora Cannabis a Good Move for Curaleaf?

David Jagielski, CPAAug 12, 2026

Person in lab gear working with marijuana plants.jpg

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

Eric VolkmanAug 12, 2026

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curaleaf

Curaleaf Holdings, Inc. is a leading cannabis company engaged in the retail and wholesale of cannabis products across the United States and internationally. The company operates licensed cultivation and pharma-grade cannabis processing facilities, supplying products to various markets including Australia, New Zealand, and several European countries.

Products and Services

Retail and wholesale cannabis products for medical and adult-use markets
Licensed cultivation and processing facilities
Medical cannabis clinics and pharmacy services

Growth Outlook

Revenue increased to $340 million in Q2 2026, reflecting strong demand
Expansion into international markets enhances growth potential
Continued investment in cultivation and processing capabilities

Financial Highlights

Net income of $13.4 million reported in Q2 2026
Gross profit margin improved to 50% in Q2 2026
Operating cash flow of $28.5 million in Q2 2026

Curaleaf Holdings, Inc. has established itself as a significant player in the cannabis industry, with a robust operational framework and a commitment to expanding its market presence. The company's recent financial performance indicates a positive trajectory, with notable revenue growth and improved profitability metrics. The strategic focus on international expansion and enhanced processing capabilities positions Curaleaf favorably for future growth. Investors may find the company's operational strengths and market opportunities compelling as the cannabis sector continues to evolve.

AI Generated • Oct 17, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,554

CEO

Boris Alexis Jordan

Website

www.curaleaf.com

Headquarters

Stamford, CT 06902, US

CURLF Financials

Key Financial Metrics (TTM)

Gross Margin

43.99%

Operating Margin

0.91%

Net Income Margin

-2.76%

Return on Equity

-4.47%

Return on Capital

1.45%

Return on Assets

-1.29%

Earnings Yield

-2.28%

Dividend Yield

0.00%

Payout Ratio

-0.05%

Stock Overview

Market Cap

$2.07B

Shares Outstanding

264.81M

Volume

246.96K

Avg. Volume

196.26K

Financials (TTM)

Gross Profit

$579.92M

Operating Income

$11.96M

EBITDA

$192.78M

Operating Cash Flow

$140.67M

Capital Expenditure

-$64.47M

Free Cash Flow

$76.20M

Cash & ST Invst.

$106.97M

Total Debt

$1.11B

Curaleaf Performance Analysis

Curaleaf annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 1,275,420,000	6.6%
2023	2023-12-31	USD 1,346,632,000	5.6%
2024	2024-12-31	USD 1,334,299,000	-0.9%
2025	2025-12-31	USD 1,268,135,000	-5.0%

Curaleaf sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	0.2%
Q4	2025-12-31	5.6%
Q1	2026-03-31	-5.5%
Q2	2026-06-30	6.4%

Curaleaf annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -1.56	76.6%
2023	2023-12-31	USD -1.17	-25.4%
2024	2024-12-31	USD -0.96	-17.2%
2025	2025-12-31	USD -1.08	11.6%

Curaleaf sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-3.2%
Q4	2025-12-31	-6.8%
Q1	2026-03-31	214.4%
Q2	2026-06-30	-81.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$340.10M

+6.4%

Gross Profit

$169.91M

+42.9%

Gross Margin

49.96%

N/A

Market Cap

$2.07B

N/A

Market Cap/Employee

$373.32K

N/A

Employees

5,554

N/A

Net Income

$12.51M

+123.1%

EBITDA

$50.02M

-20.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$106.97M

+4.4%

Total Debt

$1.11B

+32.2%

Accounts Receivable

$82.28M

+13.8%

Inventory

$244.72M

+7.8%

Long Term Debt

$1.03B

+34.5%

Short Term Debt

$86.74M

+10.1%

Return on Assets

-1.29%

N/A

Return on Invested Capital

0.48%

N/A

Free Cash Flow

$12.96M

+242.7%

Operating Cash Flow

$28.49M

+360.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VRNOVerano Holdings Corp

VRNOVerano Holdings Corp$4.89-4.68%

VREOFVireo Growth Inc.

VREOFVireo Growth Inc.$9.00-1.64%

TLRYTilray Brands, Inc.

TLRYTilray Brands, Inc.$3.04-5.30%

ACBAurora Cannabis Inc.

ACBAurora Cannabis Inc.$3.99-2.68%

CRLBFCresco Labs Inc.

CRLBFCresco Labs Inc.$0.60-4.03%

AAWHAscend Wellness Holdings, Inc.

AAWHAscend Wellness Holdings, Inc.$0.40-2.47%

VEXTFVext Science, Inc.

VEXTFVext Science, Inc.$0.18+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$89.85-5.79%

NVDANvidia

NVDANvidia$214.13-1.43%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$93.67-12.74%

CCCCCC Intelligent Solutions

CCCCCC Intelligent Solutions$7.61-0.26%

CRWVCoreWeave

CRWVCoreWeave$61.39-11.91%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.91-4.40%

RWMProShares Trust - ProShares Short Russell2000

RWMProShares Trust - ProShares Short Russell2000$14.82+1.72%

Questions About CURLF

What is the current price of Curaleaf?

Curaleaf is trading at $7.83 per share.

What is the 52-week range for Curaleaf?

Over the past 52 weeks, Curaleaf has traded between $5.40 and $15.15.

How much debt does Curaleaf have?

As of the most recent reporting period, Curaleaf reported total debt of $1.11B.

How much cash does Curaleaf have on hand?

Curaleaf reported $106.97M in cash and cash equivalents in its most recent financial results.

What is Curaleaf’s dividend yield?

Curaleaf does not currently have a dividend yield.

Curaleaf(OTC) CURLF

Curaleaf Financials at a Glance

CURLF News

The Deep Value Play for Growth Investors Isn't Artificial Intelligence, It's This Forgotten Industry

Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?

5 Best Cannabis ETFs for 2026 and How to Invest

Is Acquiring Aurora Cannabis a Good Move for Curaleaf?

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

Better Buy: Green Thumb Industries vs. Curaleaf Holdings

3 Cannabis Stocks That Could Soar After Marijuana Rescheduling

Why Curaleaf Holdings Stock Popped by Almost 25% on Tuesday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Curaleaf

CURLF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Curaleaf Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CURLF

What is the current price of Curaleaf?

What is the 52-week range for Curaleaf?

How much debt does Curaleaf have?

How much cash does Curaleaf have on hand?

What is Curaleaf’s dividend yield?

Premium Investing Services